AnaCardio raised €63M in a Series B round in Sep 2026. The company is based in Stockholm, Sweden. Investors in the round: Flerie Invest, Helsinn Investment Fund, Industrifonden and 6 others. Data as of 1 Oct 2026.
Reported in EUR — no conversion. €63M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
